Found 8 matching trials
QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC PHASE2 This study is to evaluate the efficacy and safety of QL1706 plus albumin-bo...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk TNBC Breast Cancer PHASE2 This study will look at the efficacy and safety of QL1706 plus albumin-boun...
Show More Learn More & Join Trial
FUSCC Refractory TNBC Platform Study (FUTURE2.0) PHASE2 This is a Phase II, open-label, Single-center platform study research based...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) PHASE1 This is a Phase 1, multiple dose, ascending dose escalation study to define...
Show More Location
UC San Diego Moores Cancer Center
Learn More & Join Trial
MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer. PHASE2 A Phase 2, open-label, multicenter international study will be performed to...
Show More Location
Cedars-Sinai Medical Center
Learn More & Join Trial
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors PHASE1 This study will evaluate the safety, efficacy, optimal dose, and pharmacoki...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial
Horizon Two: HR NDMM (MMRC-100) PHASE2 The Multiple Myeloma Research Consortium (MMRC) Horizon Two trial is a mast...
Show More Learn More & Join Trial